Nancy U. Lin

机构：Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center · ORCID：0000-0003-2263-5413

发表论文 1057 篇 · 总被引 44266 次 · h-index 97

代表论文

• Contrastive learning enhances fairness in pathology artificial intelligence systems (2025 · Cell Reports Medicine · 被引 7)
• Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women (2025 · JAMA Oncology · 被引 5)
• Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer (2026 · European Journal of Cancer)
• 8th International Consensus Guidelines for the management of advanced breast cancer (ABC8 Guidelines) (2026 · The Breast)
• CLTR-07 ELECTRA: AN OPEN-LABEL, MULTICENTER, PHASE 1B/2 STUDY OF ELACESTRANT IN COMBINATION WITH ABEMACICLIB IN PATIENTS WITH BRAIN METASTASES FROM ER+/HER2– BREAST CANCER (2026 · Neuro-Oncology Advances)
• TLSB-19 CENTRAL NERVOUS SYSTEM DISSEMINATION IN METASTATIC LOBULAR BREAST CANCER: A HISTOLOGY-BASED ANALYSIS (2026 · Neuro-Oncology Advances)